Redhill Biopharma
RDHL
#10406
Rank
โ‚น0.40 B
Marketcap
โ‚น78.77
Share price
-3.46%
Change (1 day)
-68.19%
Change (1 year)

EPS for Redhill Biopharma (RDHL)

EPS in 2023 (TTM): -โ‚น53,915

According to Redhill Biopharma's latest financial reports the company's current EPS (TTM) is -โ‚น65,276. In 2017 the company made an earnings per share (EPS) of -โ‚น2,33,130 a decrease over its 2016 EPS that were of -โ‚น2,05,154.

EPS history for Redhill Biopharma from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น53,915
2017-โ‚น2,33,13013.64%
2016-โ‚น2,05,1549.12%
2015-โ‚น1,88,00468.01%
2014-โ‚น1,11,902-25.93%
2013-โ‚น1,51,068

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
โ‚น192.58-100.30%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น681.37-101.04%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น351.37-100.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚น115.63-100.18%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
โ‚น113.77-100.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel